Financial reports
10-Q
2017 Q3
Quarterly report
6 Nov 17
10-Q
2017 Q2
Quarterly report
8 Aug 17
10-Q
2017 Q1
Quarterly report
10 May 17
10-K
2016 FY
Annual report
9 Mar 17
10-Q
2016 Q3
Quarterly report
10 Nov 16
10-Q
2016 Q2
Quarterly report
11 Aug 16
10-Q
2016 Q1
Quarterly report
12 May 16
10-K
2015 FY
Annual report
24 Mar 16
10-Q
2015 Q3
Quarterly report
4 Dec 15
Current reports
8-K
Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics
7 Nov 17
8-K
Ultragenyx to Acquire Dimension Therapeutics
3 Oct 17
8-K
Other Events
2 Oct 17
8-K
Dimension to Begin Discussions with Ultragenyx
19 Sep 17
8-K
Other Events
18 Sep 17
8-K
REGENXBIO to Acquire Dimension Therapeutics
25 Aug 17
8-K
Dimension Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
8 Aug 17
8-K
Departure of Directors or Certain Officers
24 Jul 17
8-K
Dimension Therapeutics Completes Strategic Review and Updates Corporate Priorities
27 Jun 17
8-K
Submission of Matters to a Vote of Security Holders
26 May 17
Registration and prospectus
15-12B
Securities registration termination
17 Nov 17
25-NSE
Exchange delisting
7 Nov 17
POS AM
Prospectus update (post-effective amendment)
7 Nov 17
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Nov 17
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Nov 17
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Nov 17
SC 14D9/A
Tender offer solicitation (amended)
7 Nov 17
SC TO-T/A
Third party tender offer statement (amended)
7 Nov 17
SC 14D9/A
Tender offer solicitation (amended)
27 Oct 17
SC 14D9/A
Tender offer solicitation (amended)
26 Oct 17
Proxies
DEFA14A
Additional proxy soliciting materials
2 Oct 17
DEFA14A
Additional proxy soliciting materials
2 Oct 17
DEFA14A
Additional proxy soliciting materials
19 Sep 17
DEFA14A
Additional proxy soliciting materials
19 Sep 17
DEFA14A
Additional proxy soliciting materials
18 Sep 17
DEFA14A
Additional proxy soliciting materials
31 Aug 17
DEFA14A
Additional proxy soliciting materials
25 Aug 17
DEFA14A
Additional proxy soliciting materials
25 Aug 17
DEF 14A
Definitive proxy
14 Apr 17
DEFA14A
Additional proxy soliciting materials
14 Apr 17
Other
EFFECT
Notice of effectiveness
13 Nov 17
CT ORDER
Confidential treatment order
9 Aug 17
EFFECT
Notice of effectiveness
22 Nov 16
CORRESP
Correspondence with SEC
18 Nov 16
UPLOAD
Letter from SEC
16 Nov 16
CT ORDER
Confidential treatment order
6 Sep 16
CT ORDER
Confidential treatment order
27 Oct 15
EFFECT
Notice of effectiveness
21 Oct 15
CORRESP
Correspondence with SEC
19 Oct 15
CORRESP
Correspondence with SEC
19 Oct 15